SUID Now Drives Over One-Third of Black-White Infant Mortality Gap After 2020
JAMA Network Open analysis of 58 million births finds SUID responsible for >33% of the post-2020 widening in Black-white infant mortality. Pandemic timing, opioid trends, and residual gaps beyond preterm birth are highlighted. Evidence is observational; causal mechanisms and intervention effects remain untested.
The JAMA Network Open study linked birth and death certificates across gestational-age strata and 13 cause-of-death categories. Preterm birth disparities remain the largest single contributor, yet SUID's share of the excess Black infant deaths increased markedly after 2020, coinciding with pandemic-related disruptions in prenatal care, respiratory-virus circulation, and rising opioid mortality in Black communities. These patterns suggest that safe-sleep interventions alone are insufficient when household stress and infectious exposures intensify.
Prior observational work from the CDC and the National Center for Health Statistics documented persistent twofold Black-white gaps but lacked granular post-2020 cause-specific decomposition; the current linked dataset reveals that even complete elimination of preterm disparities would leave a substantial residual gap driven by SUID. The study excludes Native American and Alaska Native populations, limiting generalizability, and cannot establish whether parental opioid exposure or off-season RSV/influenza surges are causal.
Public-health responses must integrate renewed safe-sleep campaigns with targeted support for families facing economic strain and substance-use disorders. Future analyses should incorporate linked prescription and vital-statistics data to test opioid-SUID hypotheses and extend surveillance to additional racial groups.
Next required evidence includes prospective cohort studies measuring household sleep environments, infection timing, and caregiver opioid exposure with infant outcome linkage.
CDC: National SUID rates for Black infants will exceed 2024 levels by at least 5% in 2026 unless state-level safe-sleep and opioid-support programs are scaled.
Sources (2)
- [1]Primary Source(https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2026.XXXXX)
- [2]Supporting Source(https://www.cdc.gov/nchs/data/nvsr/nvsr72/nvsr72-07.pdf)